Amag Pharmaceuticals, Inc.

Formerly NASDAQ: AMAG
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13D 1 page Exhibit 1 Schedule of Transactions
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 48 pages AMAG Pharmaceuticals, Inc. 3.25% Convertible Senior Notes Due 2022 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 67 pages 3,150,000 Shares AMAG Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 70 pages AMAG Pharmaceuticals, Inc. 3,977,272 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 72 pages Amag Pharmaceuticals, Inc. 2.50% Convertible Senior Notes Due 2019 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 32 pages 3,600,000 Shares AMAG Pharmaceuticals, Inc. Common Stock, $0.01 Par Value Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 34 pages 2,500,000 Shares Advanced Magnetics, Inc. Common Stock, $0.01 Par Value Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 35 pages 2,103,000 Shares Advanced Magnetics, Inc. Common Stock , $0.01 Par Value Per Share Underwriting Agreement
12/34/56
EX-1
from SC 13D/A 2 pages Amended and Restated Agreement Regarding Joint Filing
12/34/56
EX-1
from SC 13D 1 page Agreement Regarding Joint Filing
12/34/56
EX-1
from SC 13G/A 1 page Agreement Regarding Joint Filing
12/34/56
EX-1
from S-3/A ~50 pages Form of Underwriting Agreement
12/34/56